1 rich Libsyn https://www.libsyn.com 90 600 In this week’s View, Dr. Eagle looks&amp;nbsp;at&amp;nbsp;the differential&amp;nbsp;effect of&amp;nbsp;bisoprolol versus&amp;nbsp;verapamil&amp;nbsp;in nonobstructive&amp;nbsp;hypertrophic cardiomyopathy (HCM)&amp;nbsp;treatment.&amp;nbsp;He then explores&amp;nbsp;lower heart failure (HF) hospitalization risk in patients with type 2 diabetes, comparing GLP-1RAs to DPP-4 inhibitors and similar outcomes with SGLT-2 inhibitors.&amp;nbsp;Dr. Eagle&amp;nbsp;then&amp;nbsp;examines&amp;nbsp;the&amp;nbsp;use&amp;nbsp;of shared&amp;nbsp;decision-making and&amp;nbsp;decision&amp;nbsp;aids&amp;nbsp;in&amp;nbsp;percutaneous&amp;nbsp;left atrial&amp;nbsp;appendage&amp;nbsp;occlusion (LAAO).&amp;nbsp;&amp;nbsp;Finally,&amp;nbsp;the&amp;nbsp;iModern&amp;nbsp;trial,&amp;nbsp;which compares&amp;nbsp;immediate percutaneous coronary intervention (PCI) guided by instantaneous wave-free ratio (iFR) and deferred PCI guided by cardiac stress magnetic resonance imaging (MRI) in patients with STEMI and multivessel disease, is discussed.&amp;nbsp;  Subscribe to Eagle’s Eye View  &amp;nbsp;&amp;nbsp; Eagle's Eye View: Your Weekly CV Update From ACC.org http://www.acc.org <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/40397335/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/199493630